\-\ Texto\\:\\ \ \(0\)\
\-\ non\\ contributory\\.\ \(1\)\
\-\ surgical\\ resection\\ of\\ lesion\\ for\\ seizure\\ control\\ and\\ prevention\\ of\\ symptomatic\\ hemorrhage\\.\ \(0\)\
\-\ complex\\ lesion\\ with\\ cystic\\ and\\ solid\\ components\\ in\\ the\\ left\\ frontal\\ lobe\\.\\ \\ complex\\ pattern\\ of\\ high\\ and\\ low\\ signal\\ intensity\\ suggest\\ either\\ melanin\\ or\\ blood\\ products\\ within\\ the\\ lesion\\.\\ \\ little\\ or\\ no\\ mass\\ effect\\ nor\\ edema\\ suggest\\ a\\ long\\ standing\\ process\\.\\ \\ no\\ large\\ vascular\\ structures\\ are\\ present\\ on\\ mra\\.\ \(0\)\
\-\ cerebral\\ cavernous\\ malformation\\ \\(\\"hemangioma\\"\\)\ \(0\)\
\-\ vascular\\ malformation\\ \\-\\ avm\ \(0\)\
\-\ neoplasm\\ \\-\\ astrocytoma\ \(1\)\
\-\ neoplasm\\ \\-\\ glioblastoma\ \(0\)\
\-\ metastatic\\ lesion\\ \\(e\\.g\\.\\ colon\\ cancer\\)\ \(0\)\
\-\ hemorrhagic\\ metastatic\\ lesion\ \(0\)\
\-\ primary\\ or\\ metastatic\\ melanoma\ \(0\)\
\-\ 14\\ y\\.o\\.\\ girl\\ with\\ first\\ seizure\\ 3\\ months\\ prior\\ to\\ admission\\.\\ \\ she\\ was\\ treated\\ medically\\ with\\ limited\\ success\\.\\ \\ mri\\ requested\\ for\\ further\\ evaluation\\.\ \(0\)\
\-\ patient\\ developed\\ mild\\ right\\ upper\\ extremity\\ weakness\\ after\\ surgery\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lesion\\:\\ 0\\.06260990021584369\ \(0\)\
\-\ seizure\\:\\ 0\\.0543678535475233\ \(0\)\
\-\ suggest\\:\\ 0\\.05236501714234056\ \(0\)\
\-\ complex\\:\\ 0\\.04923583996567103\ \(0\)\
\-\ malformation\\:\\ 0\\.04904095902886877\ \(0\)\
\-\ melanin\\:\\ 0\\.04685563547462196\ \(0\)\
\-\ metastatic\\:\\ 0\\.04642682166077893\ \(0\)\
\-\ prevention\\:\\ 0\\.043938620308376176\ \(0\)\
\-\ neoplasm\\:\\ 0\\.041872756487941414\ \(0\)\
\-\ medically\\:\\ 0\\.04151795673556169\ \(0\)\
\-\ vascular\\:\\ 0\\.04031371608523305\ \(0\)\
\-\ \\-\\:\\ 0\\.03953370774190713\ \(0\)\
\-\ success\\:\\ 0\\.03744316914620341\ \(0\)\
\-\ products\\:\\ 0\\.03653128637182108\ \(0\)\
\-\ requested\\:\\ 0\\.03587681314731945\ \(0\)\
\-\ mra\\:\\ 0\\.034461631174326254\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.03384636373951933\ \(0\)\
\-\ little\\:\\ 0\\.03338943276309972\ \(0\)\
\-\ nor\\:\\ 0\\.032856281884295964\ \(0\)\
\-\ standing\\:\\ 0\\.032754234150540885\ \(0\)\
\-\ e\\.g\\:\\ 0\\.03255438117135329\ \(0\)\
\-\ contributory\\:\\ 0\\.031630775655898564\ \(0\)\
\-\ melanoma\\:\\ 0\\.03137533185405029\ \(0\)\
\-\ components\\:\\ 0\\.030147810148793\ \(0\)\
\-\ avm\\:\\ 0\\.02928479349354855\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.02868492580333955\ \(0\)\
\-\ cavernous\\:\\ 0\\.028514303309689792\ \(0\)\
\-\ control\\:\\ 0\\.028025449626894773\ \(0\)\
\-\ hemangioma\\:\\ 0\\.027469828418722184\ \(0\)\
\-\ 14\\:\\ 0\\.027091096523143607\ \(0\)\
\-\ admission\\:\\ 0\\.027091096523143607\ \(0\)\
\-\ either\\:\\ 0\\.026775310957983713\ \(0\)\
\-\ limited\\:\\ 0\\.025942678209532933\ \(0\)\
\-\ non\\:\\ 0\\.025412335936895757\ \(0\)\
\-\ solid\\:\\ 0\\.024520479514434385\ \(0\)\
\-\ symptomatic\\:\\ 0\\.02442434118485045\ \(0\)\
\-\ colon\\:\\ 0\\.024143402228937693\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.023873023012038103\ \(0\)\
\-\ process\\:\\ 0\\.02366953586212025\ \(0\)\
\-\ structures\\:\\ 0\\.02366953586212025\ \(0\)\
\-\ developed\\:\\ 0\\.02366953586212025\ \(0\)\
\-\ pattern\\:\\ 0\\.023499585173174665\ \(0\)\
\-\ weakness\\:\\ 0\\.02283173635272219\ \(0\)\
\-\ extremity\\:\\ 0\\.022483158054981568\ \(0\)\
\-\ intensity\\:\\ 0\\.022220652348052528\ \(0\)\
\-\ effect\\:\\ 0\\.021766606137188813\ \(0\)\
\-\ or\\:\\ 0\\.021615598898497287\ \(0\)\
\-\ girl\\:\\ 0\\.021614226122228762\ \(0\)\
\-\ cerebral\\:\\ 0\\.021298176271683966\ \(0\)\
\-\ long\\:\\ 0\\.02119583820742967\ \(0\)\
\-\ first\\:\\ 0\\.020629377228675198\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.02046227758400026\ \(0\)\
\-\ cancer\\:\\ 0\\.02020982204578968\ \(0\)\
\-\ further\\:\\ 0\\.019549957854678116\ \(0\)\
\-\ frontal\\:\\ 0\\.01931145276606732\ \(0\)\
\-\ resection\\:\\ 0\\.019172055075685028\ \(0\)\
\-\ treated\\:\\ 0\\.018401804576142874\ \(0\)\
\-\ primary\\:\\ 0\\.018211397574789182\ \(0\)\
\-\ evaluation\\:\\ 0\\.017857833063502214\ \(0\)\
\-\ y\\.o\\:\\ 0\\.017743736925084175\ \(0\)\
\-\ cystic\\:\\ 0\\.017731170555768047\ \(0\)\
\-\ edema\\:\\ 0\\.017387938772886986\ \(0\)\
\-\ she\\:\\ 0\\.017257454255065988\ \(0\)\
\-\ low\\:\\ 0\\.017094734193283452\ \(0\)\
\-\ high\\:\\ 0\\.016824072381847594\ \(0\)\
\-\ months\\:\\ 0\\.016790944566115594\ \(0\)\
\-\ blood\\:\\ 0\\.016779935773448197\ \(0\)\
\-\ lobe\\:\\ 0\\.016541908977867153\ \(0\)\
\-\ signal\\:\\ 0\\.016209167843689056\ \(0\)\
\-\ mild\\:\\ 0\\.016188873769288757\ \(0\)\
\-\ prior\\:\\ 0\\.015784983972678874\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.015108885162818829\ \(0\)\
\-\ surgery\\:\\ 0\\.014928050822735791\ \(0\)\
\-\ upper\\:\\ 0\\.01483511154941524\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.014818341740879447\ \(0\)\
\-\ 3\\:\\ 0\\.014395507386377984\ \(0\)\
\-\ mri\\:\\ 0\\.01412428672600446\ \(0\)\
\-\ present\\:\\ 0\\.013884955064256696\ \(0\)\
\-\ large\\:\\ 0\\.013442751308137265\ \(0\)\
\-\ surgical\\:\\ 0\\.012922458778787437\ \(0\)\
\-\ after\\:\\ 0\\.012719433112296421\ \(0\)\
\-\ no\\:\\ 0\\.012380491377033122\ \(0\)\
\-\ within\\:\\ 0\\.011727564089108501\ \(0\)\
\-\ for\\:\\ 0\\.01049076472867216\ \(0\)\
\-\ \\(\\:\\ 0\\.010393693902789361\ \(0\)\
\-\ \\)\\:\\ 0\\.010266729382925253\ \(0\)\
\-\ mass\\:\\ 0\\.008550079186673127\ \(0\)\
\-\ are\\:\\ 0\\.00838038757215541\ \(0\)\
\-\ was\\:\\ 0\\.007109910231753143\ \(0\)\
\-\ left\\:\\ 0\\.006878455174625286\ \(0\)\
\-\ right\\:\\ 0\\.006486559058348322\ \(0\)\
\-\ patient\\:\\ 0\\.006162531877096316\ \(0\)\
\-\ on\\:\\ 0\\.0052078490098232235\ \(0\)\
\-\ and\\:\\ 0\\.003885086454652197\ \(0\)\
\-\ to\\:\\ 0\\.003072432434841628\ \(0\)\
\-\ \\.\\:\\ 0\\.0030647081522888874\ \(0\)\
\-\ in\\:\\ 0\\.003031634749210467\ \(0\)\
\-\ a\\:\\ 0\\.002853235984306484\ \(0\)\
\-\ with\\:\\ 0\\.002525269987551577\ \(0\)\
\-\ of\\:\\ 0\\.002514470520819894\ \(0\)\
\-\ the\\:\\ 0\\.001989198341059364\ \(0\)\
